# FDA Inspection 1225275 - Janssen Pharmaceuticals Inc. - December 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/f5eb5852-3f6a-4246-a387-cf35044c8d21
Source feed: FDA_Inspections

> FDA Inspection 1225275 for Janssen Pharmaceuticals Inc. on December 14, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225275
- Company Name: Janssen Pharmaceuticals Inc.
- Inspection Date: 2023-12-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1252007 - 2024-11-01](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/6cf9b413-b5b9-41ea-a1db-605ee18bf2ee)
- [FDA Inspection 1175643 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/96ba00a9-75a4-42fe-8c7e-317d1ee03074)
- [FDA Inspection 998113 - 2017-01-26](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3ea6272-4a0c-4c2c-a92b-37b8191ae003)
- [FDA Inspection 965139 - 2016-01-22](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3173e7d-2caa-4560-acd5-80f483d514bf)
- [FDA Inspection 833775 - 2013-05-21](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/7142c62c-b7f3-4997-aa1a-ced0ebfb4d44)

Company: https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d